OncoPep Receives $2,525,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d8caf6d4-61c7-416b-89fa-af47c3073fde&Preview=1 - Date
4/27/2012 - Company Name
OncoPep - Mailing Address
520 Boston Street North Andover, MA 01845 - Company Description
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. - Website
http://www.oncopep.com - Transaction Type
Venture Equity - Transaction Amount
$2,525,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
